Projects per year
Fingerprint
Dive into the research topics where Robert Patrick Doyle is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Targeting the GDF15-GFRAL System to Treat Nausea and Emesis
8/9/21 → 5/31/25
Project: Sponsored Project
-
Second Generation GLP-1 Agonists without Nausea/emesis Side Effects
3/1/21 → 6/30/23
Project: Sponsored Project
-
B12-chloroquine and B12-mRNA Conjugates Development in Combination with Intrinsic Factor
3/1/21 → 2/28/22
Project: Sponsored Project
-
Appetite-Suppressing Effects of Novel Glucoregulatory Chimeric Peptides Devoid Nausea
6/1/20 → 5/31/23
Project: Sponsored Project
-
Proposal to Investigate Magnesium Chelates of Interest of Balchem Corporation
9/9/19 → 8/31/21
Project: Sponsored Project
-
Peripherally restricted oxytocin is sufficient to reduce food intake and motivation, while CNS entry is required for locomotor and taste avoidance effects
Asker, M., Krieger, J. P., Liles, A., Tinsley, I. C., Borner, T., Maric, I., Doebley, S., Furst, C. D., Börchers, S., Longo, F., Bhat, Y. R., De Jonghe, B. C., Hayes, M. R., Doyle, R. P. & Skibicka, K. P., Mar 2023, In: Diabetes, Obesity and Metabolism. 25, 3, p. 856-877 22 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Complexes of Magnesium Maltol (3-Hydroxy-2-methyl-4H-pyran-4-one) for Oral Supplementation
Doyle, R. P. & Case, D., Mar 24 2022, Sep 17 2021, Priority date Sep 17 2020, Priority No. 63/079,743Research output: Patent
-
Glucagon-like peptide-1 in diabetes care: Can glycaemic control be achieved without nausea and vomiting?
Borner, T., Tinsley, I. C., Doyle, R. P., Hayes, M. R. & De Jonghe, B. C., Feb 2022, In: British Journal of Pharmacology. 179, 4, p. 542-556 15 p.Research output: Contribution to journal › Review article › peer-review
8 Scopus citations -
Monomeric Peptide Multi-Agonist Targeting the GLP1 Receptor and NPY Receptors
Doyle, R. P. & Milliken, B. T., Jun 30 2022, Apr 1 2020, Priority date Apr 1 2019, Priority No. 62/827,229Research output: Patent
-
Peptide Drug Improvement Using Vitamin B12 and Haptocorrin Binding Substrate Conjugates
Doyle, R. P., Jun 16 2022, Dec 22 2021, Priority date Aug 9 2016, Priority No. 62/372,605Research output: Patent
Press and Media
-
DEVELOPING A DRUG TO FIGHT DIABETES AND OBESITY IN VETERANS
5/11/20
1 item of Media coverage
Press/Media: Expert Comment
-
DAYLONG SYMPOSIUM TO HIGHLIGHT LIFE SCIENCES RESEARCH NOV. 3
10/25/18
1 item of Media coverage
Press/Media: Expert Comment